Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02471014 · ClinicalTrials.gov registry record

Effect of Obesity on Immune Response to Pneumovax 23

A clinical trial of Obesity, sponsored by University of Florida.

Completed
Registry status
50
Enrollment target
1
Study location

NCT02471014: Completed study of Obesity, sponsored by University of Florida.

NCT02471014 is a study of Obesity that has completed, run by University of Florida. The registered enrollment target is 50 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02471014, a study of Obesity, has completed, sponsored by University of Florida.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

Pneumococcal infections are a leading cause of adult and childhood hospitalization and death. It has been shown that obese individuals are at higher risk for this bacterial infection. As a result, investigators will vaccinate obese individuals to see if they are offered the same level of protection from the vaccine as normal-weight individuals. The vaccine used for this particular bacterial infection is called Pneumovax 23. The purpose of this study is to compare how body mass index affects protection that the vaccine provides against these bacteria. Primary Hypothesis: Levels of protection from the vaccine are no different in pre- and post- vaccination in healthy BMI individuals and obese individuals.

Primary Outcome

IgG antibody titers specific for each serotype in Pneumovax 23 (i.e. 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F) will be analyzed.

Conditions Studied

Obesity

Interventions

  • OTHER Questionnaires
  • OTHER Blood tests
  • DRUG Pneumovax 23

Study Locations (1)

Florida

  • Uf Ctsi Crc - Gainesville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-12
Est. Completion 2019-05-16
University of Florida

1,106 total trials

What the finished NCT02471014 record still lists

NCT02471014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Questionnaires is the first listed.

NCT02471014 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02471014 about?

NCT02471014 is a clinical study titled "Effect of Obesity on Immune Response to Pneumovax 23". Pneumococcal infections are a leading cause of adult and childhood hospitalization and death. It has been shown that obese individuals are at higher risk for this bacterial infection. As a result, investigators will vaccinate obese individuals to see if they are offered the same level of protection ...

What is the current status of trial NCT02471014?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-12. Estimated completion is 2019-05-16.

What conditions does trial NCT02471014 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02471014?

The interventions under investigation include: Questionnaires (OTHER), Blood tests (OTHER), Pneumovax 23 (DRUG).

Who is sponsoring clinical trial NCT02471014?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02471014 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02471014's enrollment target sits among peer trials

50 714th of 1053 higher than 324 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02471014, the US trial registry maintained by the National Library of Medicine. NCT02471014 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.